It has been shown that the inhibition of nSMase2/Smpd3 enzymatic activity ameliorates skeletal muscles of muscular dystrophy in mdx mice, in turn, inhibits ceramide synthesis [150]. The gene discussed is SMPD3; the disease is muscular dystrophy.